23. Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, et al. (1997) Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci U S A 94: 12053–12058. 24. Kurihara T, Warr G, Loy J, Bravo R (1997) Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 186: 1757–1762. 25. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, et al. (1998) Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein-1-deficient mice. J Exp Med 187: 601–608. 26. Brodmerkel CM, Huber R, Covington M, Diamond S, Hall L, et al. (2005) Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344. J Immunol 175: 5370–5378. 27. Shin N, Baribaud F, Wang K, Yang G, Wynn R, et al. (2009) Pharmacological characterization of INCB3344, a small molecule antagonist of human CCR2. Biochem Biophys Res Commun 387: 251–255. 28. Dansereau MA, Gosselin RD, Pohl M, Pommier B, Mechighel P, et al. (2008) Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats. J Neurochem 106: 757–769. 29. Intyte (2006) CCR2 ANTAGONIST PROGRAM. Orally-Administered Therapeutics for Inflammation-Driven Diseases. Available: http://www.incyte. com/backgrounders/A%20CCR2%20Backgrounder.pdf. 30. Luhmann UF, Robbie S, Munro PM, Barker SE, Duran Y, et al. (2009) The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest Ophthalmol Vis Sci 50: 5934–5943. 31. Campa C, Kasman I, Ye W, Lee WP, Fuh G, et al. (2008) Effects of an anti- VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changes. Invest Ophthalmol Vis Sci 49: 1178–1183. 32. Imamura Y, Noda S, Hashizume K, Shinoda K, Yamaguchi M, et al. (2006) Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunc- tion in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci U S A 103: 11282–11287. 33. Itaya M, Sakurai E, Nozaki M, Yamada K, Yamasaki S, et al. (2007) Upregulation of VEGF in murine retina via monocyte recruitment after retinal scatter laser photocoagulation. Invest Ophthalmol Vis Sci 48: 5677–5683. 34. Curry JM, Eubank TD, Roberts RD, Wang Y, Pore N, et al. (2008) M-CSF signals through the MAPK/ERK pathway via Sp1 to induce VEGF production and induces angiogenesis in vivo. PLoS One 3: e3405. 35. Koto T, Nagai N, Mochimaru H, Kurihara T, Izumi-Nagai K, et al. (2007) Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascu- larization in mice. Invest Ophthalmol Vis Sci 48: 4328–4334. 36. Caicedo A, Espinosa-Heidmann DG, Pin˜ a Y, Hernandez EP, Cousins SW (2005) Blood-derived macrophages infiltrate the retina and activate Muller glial cells under experimental choroidal neovascularization. Exp Eye Res 81: 38–47. 37. Izumi-Nagai K, Nagai N, Ohgami K, Satofuka S, Ozawa Y, et al. (2007) Macular pigment lutein is antiinflammatory in preventing choroidal neovascu- larization. Arterioscler Thromb Vasc Biol 27: 2555–2562. CCR2 Blocker Inhibits Choroidal Neovascularization 38. Goyal S, Chauhan SK, Zhang Q, Dana R (2009) Amelioration of murine dry eye disease by topical antagonist to chemokine receptor 2. Arch Ophthalmol 127: 882–887. 39. Krzystolik MG, Afshari MA, Adamis AP, Gaudreault J, Gragoudas ES, et al. (2002) Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 120: 338–346. 40. Kvanta A, Algvere PV, Berglin L, Seregard S (1996) Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci 37: 1929–1934. 41. Wang J, Ohno-Matsui K, Yoshida T, Shimada N, Ichinose S, et al. (2009) Amyloid-beta up-regulates complement factor B in retinal pigment epithelial cells through cytokines released from recruited macrophages/microglia: Another mechanism of complement activation in age-related macular degeneration. J Cell Physiol 220: 119–128. 42. Cousins SW, Espinosa-Heidmann DG, Csaky KG (2004) Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization? Arch Ophthalmol 122: 1013–1018. 43. Oh H, Takagi H, Takagi C, Suzuma K, Otani A, et al. (1999) The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci 40: 1891–1898. 44. Inoue Y, Yanagi Y, Matsuura K, Takahashi H, Tamaki Y, et al. (2007) Expression of hypoxia-inducible factor 1alpha and 2alpha in choroidal neovascular membranes associated with age-related macular degeneration. Br J Ophthalmol 91: 1720–1721. 45. Sodhi A, Biswas SK (2002) Monocyte chemoattractant protein-1-induced activation of p42/44 MAPK and c-Jun in murine peritoneal macrophages: a potential pathway for macrophage activation. J Interferon Cytokine Res 22: 517–526. 46. Wain JH, Kirby JA, Ali S (2002) Leucocyte chemotaxis: Examination of mitogen-activated protein kinase and phosphoinositide 3-kinase activation by Monocyte Chemoattractant Proteins-1, -2, -3 and -4. Clin Exp Immunol 127: 436–444. 47. Yen H, Zhang Y, Penfold S, Rollins BJ (1997) MCP-1-mediated chemotaxis requires activation of non-overlapping signal transduction pathways. J Leukoc Biol 61: 529–532. 48. Cambien B, Pomeranz M, Millet MA, Rossi B, Schmid-Alliana A (2001) Signal transduction involved in MCP-1-mediated monocytic transendothelial migra- tion. Blood 97: 359–366. 49. Liu S, Yang P, Kang H, Lu L, Zhang Y, et al. (2010) NDRG2 induced by oxidized LDL in macrophages antagonizes growth factor productions via selectively inhibiting ERK activation. Biochim Biophys Acta 1801: 106–113. 50. Hashizume K, Hirasawa M, Imamura Y, Noda S, Shimizu T, et al. (2008) Retinal dysfunction and progressive retinal cell death in SOD1-deficient mice. Am J Pathol 172: 1325–1331. 51. Ambati J, Anand A, Fernandez S, Sakurai E, Lynn BC, et al. (2003) An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2- deficient mice. Nat Med 9: 1390–1397. PLoS ONE | www.plosone.org 10 December 2011 | Volume 6 | Issue 12 | e28933